LLY compared with OLMA: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

OLMAOlema Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

OLMAOlema Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

OLMA: latest quarter not drawable.Method ›

LLYELI Lilly & Co

1,433.53▲+1.10%

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

OLMAOlema Pharmaceuticals, Inc.

7.540.00%

Regular sessionNov 5 '26

Mkt cap$659.7MRevenue—Revenue—

Compare

Regular sessionNov 5 '26

LLYELI Lilly & Co

OLMAOlema Pharmaceuticals, Inc.

1,433.53▲+1.10%

Price

7.540.00%

$1.3T

Mkt cap

$659.7M

Q3 FY26$24.4B

Revenue

—

FY25$65.2B

Revenue

—

LLY1,433.53▲+1.10%vsOLMA7.540.00%Regular sessionNov 5 '26

Price

rebased to 0%

LLY, solidOLMA, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Shared 0

No shared counterparties.

Only OLMA 5

PFEPfizersupplier

NVSNovartis Pharma AG (Novartis)supplier

—Aurigeneunlistedsupplier

—Aurigene Oncology

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlistedsupplier

1 more · OLMA chain ›